pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3179-1 |
Genomic Coordinates | chr16: 14901508 - 14901591 |
Description | Homo sapiens miR-3179-1 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-2 |
Genomic Coordinates | chr16: 16300159 - 16300242 |
Description | Homo sapiens miR-3179-2 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-3 |
Genomic Coordinates | chr16: 18411894 - 18411977 |
Description | Homo sapiens miR-3179-3 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-mir-3179-4 |
Genomic Coordinates | chr16: 18494493 - 18494576 |
Description | Homo sapiens miR-3179-4 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3179 | |||||||||||||||
Sequence | 52| AGAAGGGGUGAAAUUUAAACGU |73 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MYO1C | ||||||||||||||||||||
Synonyms | MMI-beta, MMIb, NMI, myr2 | ||||||||||||||||||||
Description | myosin IC | ||||||||||||||||||||
Transcript | NM_001080779 | ||||||||||||||||||||
Other Transcripts | NM_001080950 , NM_033375 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MYO1C | |||||||||||||||||||||
3'UTR of MYO1C (miRNA target sites are highlighted) |
>MYO1C|NM_001080779|3'UTR 1 TAAAGGCGCCCACTGGACCCTCCCAACGCCCAATGCTTTGCTTTTCTCCTCCTCCCCTTCCCAGTTACCAAAGACTCGAA 81 CTTCCAGACAGGGACCCAGGGACACCCCGAAGCCCACCTGCAATCTCCCACCTCCTGCCCATCCCTCTCTTGAGGGAGCA 161 GCAGGGGCCAGGAGCTACCCCAGGAGTGGGCCAGGCCGGGCCACAGCAATAGGAAAGCCAGGGCCAGAGCGAGCCATGCC 241 AGCCCTACTGCCGATGCCAAATATTTGAGAGAAGGGAACTTTTGCTGAGGTTTTCTCTGAGGTTTTTTTGATGCTTTATA 321 GGAAACTATTTTTTAAAAAAAGCCATTTCCCACCCAAGGACACAGTGGATGTGTTTTCCCTGACTCCAGCAGGGCAAGGA 401 ATGTAGCCGAGAGGTTGTGTGGGCTGGGCTCTGGTGCCCTCTTCCCTGGCCAGGACACCTCTCCTCCTGATTCCCTTGGC 481 ACCTTGTCTTTCTGTCTGTTTACCTGTCTCCCTGCCTGCCCATCTGCATCTTTTGCAGCCCACTCTGACTTCCATCTGGG 561 GGCTGAGACCACCCTTGCCTGCCCCCTTCTTTCTGCCTTAAGAATGTCCTTTTAGGCTGGGCATGGTGGCTCACGCCTGT 641 AACCCCAGCACTTTGGGAGGCGGAGACGGGCAGATAACCTGAGGTCAGGATTTCGAGACCAACCTGACCTACATGGAGAA 721 ACTCCGCCTCTAGTAAAAATACAAAATTAGCCGGGCATGGTGGTGCACGCCTCTAATCCCAGCTACTCGGGAGGCTGAGG 801 CAGGAGAATCACTTGAACCCGGGAAGTGGAGGTTGCAGTGAGCCAAGAGTACACCACTGCACTCCAGCCTGGGCAACAGA 881 GCGAGACTCCGTCTTAAAAAAAAAAAAAAAGAACGCCCTTTTACTGTCCTCATCATCCCAGTTTGAGGCAGTGCTGGAGT 961 GGGGAAGGCCGTCTTAGACCATAGAGGTTGGAAGACGCTGAGAGATCATCCAGCCCAGCCCCTTGATGTTACAGAGCAGA 1041 AGACAGATGCCCAAACAGGAGAAGGCACTTGCCCACGGTCATACGGCAGGTTGCCACAAAACCAAGATGGCAGCCCTTCC 1121 TCAGCGTGCCTCACTGCCACTCCCAGAGCCAGGGAGCCCCATAAAACCCACATCATGTCTTAAGAGTATATCTGGCTCCT 1201 TGACCAGCAATCGGCCCTGGGAGCCACCAGGTGGGAAAAGCGCCTCTGCCAGAGTCCAGGCCTTGGGATGACAGACAGCT 1281 TGCCCGCACACTCGGGCCCCACTCAAGGATGTAGGGCCTTTTCTGGCCCCTGACCCCTCCCTGGCATGGGAGCGTGGGGA 1361 CGGGGCTGGCCTTGGGAGGAGCGGCAGGGGCATCACCTCCTTCTGCTGCTTCTCCCTGCTCCTACCCTCAAGGGCCTGGG 1441 GGCTGCCCAGCTGCCTCTATGCCCTTCTGGGGGTCTCAGCCCACTGCTGACACTTCTGCAATCCAGAGAAACACTAAATA 1521 AAGCAATACGTGTTTGCCAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545215. RNA binding protein: AGO4. Condition:Control
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462573. RNA binding protein: AGO2. Condition:TZM-bl BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HCT116 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177622. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_3_12
PAR-CLIP data was present in ERX177634. RNA binding protein: AGO2. Condition:KO_V_AGO_CLIP_4_12
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_001080950 | 3UTR | CCCCUUCCCAGUUACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903830 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_b |
Location of target site | NM_001080950 | 3UTR | CCCCUUCCCAGUUACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM545215 | |
---|---|
Method / RBP | PAR-CLIP / AGO4 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000359786.5 | 3UTR | UCUCCUCCUCCCCUUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000359786.5 | 3UTR | CUCCUCCUCCCCUUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1462573 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl BaL |
Location of target site | ENST00000359786.5 | 3UTR | UUCUCCUCCUCCCCUUCCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
133 hsa-miR-3179 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT102087 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT110061 | OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | ![]() |
![]() |
2 | 6 | ||||||
MIRT112198 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT117668 | SCAMP4 | secretory carrier membrane protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT146657 | MINK1 | misshapen like kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT175505 | ZBTB33 | zinc finger and BTB domain containing 33 | ![]() |
![]() |
2 | 4 | ||||||
MIRT180535 | TXNIP | thioredoxin interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT190624 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT190650 | PABPN1 | poly(A) binding protein nuclear 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366902 | NONO | non-POU domain containing octamer binding | ![]() |
![]() |
2 | 2 | ||||||
MIRT443554 | ZFP3 | ZFP3 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT445953 | MLLT11 | MLLT11, transcription factor 7 cofactor | ![]() |
![]() |
2 | 2 | ||||||
MIRT446042 | HMCN1 | hemicentin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT447968 | MSH6 | mutS homolog 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448634 | ONECUT1 | one cut homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449316 | MRO | maestro | ![]() |
![]() |
2 | 2 | ||||||
MIRT451380 | C19orf43 | telomerase RNA component interacting RNase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451547 | CIAPIN1 | cytokine induced apoptosis inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT451807 | CDCA3 | cell division cycle associated 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT451916 | ILK | integrin linked kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT451938 | TMPRSS5 | transmembrane protease, serine 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452189 | KIAA1456 | KIAA1456 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452498 | HMGXB3 | HMG-box containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452548 | ZNF467 | zinc finger protein 467 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453844 | SDK1 | sidekick cell adhesion molecule 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454515 | ZFYVE27 | zinc finger FYVE-type containing 27 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455363 | KDM5C | lysine demethylase 5C | ![]() |
![]() |
2 | 2 | ||||||
MIRT455455 | EPB41L4B | erythrocyte membrane protein band 4.1 like 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT455628 | PABPC1L2B | poly(A) binding protein cytoplasmic 1 like 2B | ![]() |
![]() |
2 | 10 | ||||||
MIRT455639 | PABPC1L2A | poly(A) binding protein cytoplasmic 1 like 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT455690 | GLO1 | glyoxalase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT456300 | ASH1L | ASH1 like histone lysine methyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT456784 | MTHFSD | methenyltetrahydrofolate synthetase domain containing | ![]() |
![]() |
2 | 2 | ||||||
MIRT456819 | PIGP | phosphatidylinositol glycan anchor biosynthesis class P | ![]() |
![]() |
2 | 2 | ||||||
MIRT457566 | ZNF34 | zinc finger protein 34 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457604 | IDS | iduronate 2-sulfatase | ![]() |
![]() |
2 | 2 | ||||||
MIRT458236 | NXPH3 | neurexophilin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458313 | TNFAIP8L3 | TNF alpha induced protein 8 like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT458350 | NOC2L | NOC2 like nucleolar associated transcriptional repressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT458670 | GPR35 | G protein-coupled receptor 35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459675 | VPS37C | VPS37C, ESCRT-I subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT461126 | RAB36 | RAB36, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT461918 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462301 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | ![]() |
![]() |
2 | 2 | ||||||
MIRT463520 | ZBTB7B | zinc finger and BTB domain containing 7B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464378 | URM1 | ubiquitin related modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464614 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT464711 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465520 | PRICKLE4 | prickle planar cell polarity protein 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT465974 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT466058 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466548 | TBL1XR1 | transducin beta like 1 X-linked receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT466647 | TAGLN2 | transgelin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467357 | SP2 | Sp2 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT468744 | SDC2 | syndecan 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470244 | PRRC2A | proline rich coiled-coil 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT471426 | PDIA6 | protein disulfide isomerase family A member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471732 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472190 | NHP2L1 | small nuclear ribonucleoprotein 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472450 | NAV2 | neuron navigator 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT474563 | KLHDC3 | kelch domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT474936 | KCTD15 | potassium channel tetramerization domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475165 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475399 | ICMT | isoprenylcysteine carboxyl methyltransferase | ![]() |
![]() |
2 | 4 | ||||||
MIRT475426 | ICK | intestinal cell kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT477090 | FAM168A | family with sequence similarity 168 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT478458 | DAB2 | DAB2, clathrin adaptor protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT478953 | COX15 | COX15, cytochrome c oxidase assembly homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT480096 | CALR | calreticulin | ![]() |
![]() |
2 | 2 | ||||||
MIRT481924 | ANKRD33B | ankyrin repeat domain 33B | ![]() |
![]() |
2 | 2 | ||||||
MIRT483217 | APOA1 | apolipoprotein A1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT483882 | TGIF1 | TGFB induced factor homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483923 | SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483942 | LENG8 | leukocyte receptor cluster member 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT484209 | SUMO1 | small ubiquitin-like modifier 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484512 | SYT7 | synaptotagmin 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT484709 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485356 | MYO1C | myosin IC | ![]() |
![]() |
2 | 4 | ||||||
MIRT485615 | FOSL1 | FOS like 1, AP-1 transcription factor subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT486584 | ZNF619 | zinc finger protein 619 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487013 | C2orf82 | chromosome 2 open reading frame 82 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487621 | C20orf96 | chromosome 20 open reading frame 96 | ![]() |
![]() |
2 | 2 | ||||||
MIRT487801 | GPR20 | G protein-coupled receptor 20 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488134 | GPR107 | G protein-coupled receptor 107 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488773 | FXYD1 | FXYD domain containing ion transport regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT488854 | UBTF | upstream binding transcription factor, RNA polymerase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT489783 | GRINA | glutamate ionotropic receptor NMDA type subunit associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490102 | FN3K | fructosamine 3 kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT490389 | LHFPL3 | LHFPL tetraspan subfamily member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490434 | MYL9 | myosin light chain 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490451 | GLUD1 | glutamate dehydrogenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT490880 | OSBP | oxysterol binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT491037 | ALPK3 | alpha kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491250 | HCN2 | hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491748 | SEMA3F | semaphorin 3F | ![]() |
![]() |
2 | 2 | ||||||
MIRT492235 | SLC48A1 | solute carrier family 48 member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492490 | RAPGEF1 | Rap guanine nucleotide exchange factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492505 | RANBP10 | RAN binding protein 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT492773 | PDGFB | platelet derived growth factor subunit B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492922 | NFAT5 | nuclear factor of activated T-cells 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493459 | ITFG3 | family with sequence similarity 234 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT493654 | HDLBP | high density lipoprotein binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT494011 | DUSP9 | dual specificity phosphatase 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499412 | PLCG2 | phospholipase C gamma 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT499552 | C15orf43 | telomere repeat binding bouquet formation protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501836 | NCOA2 | nuclear receptor coactivator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT501950 | MAT2A | methionine adenosyltransferase 2A | ![]() |
![]() |
2 | 10 | ||||||
MIRT504066 | KCTD12 | potassium channel tetramerization domain containing 12 | ![]() |
![]() |
2 | 4 | ||||||
MIRT504509 | PPP1R9B | protein phosphatase 1 regulatory subunit 9B | ![]() |
![]() |
2 | 2 | ||||||
MIRT508466 | HOXB6 | homeobox B6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT512373 | CPM | carboxypeptidase M | ![]() |
![]() |
2 | 2 | ||||||
MIRT513578 | EVX1 | even-skipped homeobox 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517763 | ZNF366 | zinc finger protein 366 | ![]() |
![]() |
2 | 4 | ||||||
MIRT519773 | ZNF354B | zinc finger protein 354B | ![]() |
![]() |
2 | 8 | ||||||
MIRT523568 | GGCX | gamma-glutamyl carboxylase | ![]() |
![]() |
2 | 4 | ||||||
MIRT532802 | CLDN11 | claudin 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544299 | TSPYL1 | TSPY like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544862 | MYH2 | myosin heavy chain 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT556731 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT564347 | AKR1B10 | aldo-keto reductase family 1 member B10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT568924 | SMCR8 | Smith-Magenis syndrome chromosome region, candidate 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569012 | CXorf36 | chromosome X open reading frame 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569256 | FAM129B | family with sequence similarity 129 member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT569591 | PRELP | proline and arginine rich end leucine rich repeat protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT569779 | SAMD14 | sterile alpha motif domain containing 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570034 | FAM228A | family with sequence similarity 228 member A | ![]() |
![]() |
2 | 2 | ||||||
MIRT573803 | FRMPD4 | FERM and PDZ domain containing 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574190 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576153 | Hmox1 | heme oxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT611311 | CA8 | carbonic anhydrase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT673429 | APAF1 | apoptotic peptidase activating factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674976 | SH3BP2 | SH3 domain binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692712 | MEAF6 | MYST/Esa1 associated factor 6 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|